Call For Universal Seasonal Flu Jab For All Young Children
There is a case for universal vaccination of children aged six months to five years with the seasonal flu jab, suggest Professor David Mant and colleague Consultant Epidemiologist Richard Mayon-White, in an editorial1 in this month's British Journal of General Practice (BJGP). The researchers from Oxford University feel that children in at-risk groups, such as those with asthma, would benefit more if the flu vaccine was added to the current childhood vaccination programme, as well as benefiting others they come into contact with such as their grandparents.
Injection Safety Efforts Eliminate Immunization-related Infections In Sub-Saharan Africa
The Measles Initiative and the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunisation) announced today that infections resulting from the re-use of syringes for immunizations have been reduced to practically zero in sub-Saharan Africa, according to a study released in the Supplement of the Journal of Infectious Diseases. Over the past decade, advocacy efforts and the funding of safe injection materials, including auto-disable (AD) syringes, have virtually eliminated the dangerous practice of reusing syringes for vaccinations in sub-Saharan Africa.
News From The Journal Of Clinical Investigation: July 1, 2011
ONCOLOGY: Role for stem cells in tumor development Ovarian cancer is the fifth most common cancer among women. New research, performed by Ronald Buckanovich and colleagues, at the University of Michigan Medical Center, Ann Arbor, provides insight into the cellular and molecular mechanisms that promote ovarian tumor development and thereby identifies a potential new therapeutic approach. Mesenchymal stem cells (MSCs) are multipotent cells that have the capacity to generate many different cell types, including bone cells, cartilage cells, and fat cells.